Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Classic s
A Multi-center, Prospective and Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Classic s Injected Into the Nasolabial Folds
Sponsor: LG Life Sciences
A observational or N/A phase clinical study on Correction of Nasolabial Folds, this trial is completed. The trial is conducted by LG Life Sciences and has accumulated 10 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2023 — Jul 2024 [monthly]
Completed
-
Dec 2022 — Jan 2023 [monthly]
Completed
-
Jan 2021 — Dec 2022 [monthly]
Completed
▶ Show 5 earlier versions
-
Apr 2019 — Jan 2021 [monthly]
Completed
Status: Unknown Status → Completed
-
Jun 2018 — Apr 2019 [monthly]
Unknown Status
-
Apr 2018 — Jun 2018 [monthly]
Unknown Status
Phase: NA → None
-
Oct 2017 — Apr 2018 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jan 2017 — Oct 2017 [monthly]
Active Not Recruiting NA
First recorded
Sep 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- LG Life Sciences
For direct contact, visit the study record on ClinicalTrials.gov .